Per the terms of the agreement, Novavax will receive an upfront payment of $30 million from Pfizer and is eligible to earn up to $500 million in potential development and commercial milestone payments ...

Novavax secures a non-exclusive licensing deal with Pfizer, validating Matrix-M's platform value and shifting NVAX toward a technology provider model. NVAX receives $30M upfront, a potential $500M in ...

Novavax has agreed to a deal to let Pfizer use Matrix-M adjuvant in its products for an upfront payment of $30 million and up to another $500 million in milestone payments. The biotech company said ...

Pfizer is paying $30 million to use Novavax’s adjuvant technology to improve the efficacy of two of the Big Pharma’s vaccine programs. The tech, called Matrix-M, is designed to trigger an immune ...

A team of New York University scientists has created a gear mechanism that relies on fluids to generate rotation. The invention holds potential for a new generation of mechanical devices that offer ...

The Astros officially introduced Tatsuya Imai at Daikin Park this morning. The surprising three-year deal continues what has been a pitching-focused offseason for a Houston team losing Framber Valdez ...

For the fastest way to join Tom's Guide Club enter your email below. We'll send you a confirmation and sign you up to our newsletter to keep you updated on all the latest news. By submitting your ...

Most offensive line rotations don't work out well. It's a position where continuity matters. But the Detroit Lions had success shuffling offensive guards in last week's win over the Dallas Cowboys, ...